Skip to main content Help with accessibility Skip to main navigation

GLIPTINS (Dipeptidylpeptidase-4 [DPP-4] inhibitors)

CCG Approval Status:

Ha
Kn
Li
SF
SS
SH
Wa
WL
Wi
Date Added: 01 - Dec - 2025
Body System:
Green
GLIPTINS (Dipeptidylpeptidase-4 [DPP-4] inhibitors)

The Pan Mersey Area Prescribing Committee recommends the prescribing of DPP-4 inhibitors in accordance with NG28-Type 2 diabetes in adults: management.